» Articles » PMID: 23031592

Downregulation of Mdr1 and Abcg2 Genes is a Mechanism of Inhibition of Efflux Pumps Mediated by Polymeric Amphiphiles

Overview
Specialty Biochemistry
Date 2012 Oct 4
PMID 23031592
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The ability of cells to acquire resistance to multiple pharmaceuticals, namely multidrug resistance (MDR), is often mediated by the over-expression of efflux transporters of the ATP-binding cassette (ABC) superfamily; for example P-glycoprotein (P-gp or MDR1), breast cancer resistance protein (BCRP or ABCG2), and multidrug resistance-associated protein MRP1. ABCs pump drug molecules out of cells against a concentration gradient, reducing their intracellular concentration. The ability of polymeric amphiphiles to inhibit ABCs as well as the cellular pathways involved in the inhibition has been extensively investigated. This work investigated for the first time the effect of branched poly(ethylene oxide)-poly(propylene oxide) block copolymers (poloxamines) on the levels of mRNA encoding for MDR1, BCRP and MRP1, in a human hepatoma cell line (Huh7). Copolymers with a broad range of molecular weights and hydrophilic-lipophilic balances were assayed. Results confirmed the down-regulation of mdr1 and abcg2 genes. Conversely, the mrp1 gene was not affected. These findings further support the versatility of these temperature- and pH-responsive copolymers to overcome drug resistance in cancer and infectious diseases.

Citing Articles

Epidermal Growth Factor Receptor Inhibitor Mobocertinib Resensitizes Multidrug-Resistant Cancer Cells by Attenuating the Human ATP-Binding Cassette Subfamily B Member 1 and Subfamily G Member 2.

Li Y, Hsiao S, Murakami M, Huang Y, Chang Y, Hung T ACS Pharmacol Transl Sci. 2024; 7(1):161-175.

PMID: 38230272 PMC: 10789147. DOI: 10.1021/acsptsci.3c00217.


Imperatorin Restores Chemosensitivity of Multidrug-Resistant Cancer Cells by Antagonizing ABCG2-Mediated Drug Transport.

Wu C, Murakami M, Li Y, Huang Y, Chang Y, Hung T Pharmaceuticals (Basel). 2023; 16(11).

PMID: 38004460 PMC: 10674403. DOI: 10.3390/ph16111595.


Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells.

Wu C, Li Y, Murakami M, Hsiao S, Lee Y, Huang Y Int J Mol Sci. 2023; 24(18).

PMID: 37762275 PMC: 10531071. DOI: 10.3390/ijms241813972.


Hydroxygenkwanin Improves the Efficacy of Cytotoxic Drugs in ABCG2-Overexpressing Multidrug-Resistant Cancer Cells.

Li Y, Murakami M, Huang Y, Hung T, Wang S, Wu Y Int J Mol Sci. 2022; 23(21).

PMID: 36361555 PMC: 9658017. DOI: 10.3390/ijms232112763.


The multi-targeted tyrosine kinase inhibitor SKLB610 resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs.

Wu C, Murakami M, Wu Y, Lin C, Li Y, Huang Y Biomed Pharmacother. 2022; 149:112922.

PMID: 36068781 PMC: 10506422. DOI: 10.1016/j.biopha.2022.112922.